Project Grant K23HD120657
- The National Institute of Child Health and Human Development awarded Arizona State University $160,620 on June 1, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to characterize bilateral ankle mechanics post-stroke and their relationship to impaired posture and gait function. The project addresses knowledge gaps in how stroke affects ankle joint control during upright posture and walking. Previous stroke research has been limited to seated...
- The National Institute of Child Health and Human Development, part of the National Institutes of Health, awarded the University of Illinois $110,228 on December 3, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to develop a markerless motion-capture tool for objectively evaluating motor impairments in stroke survivors. The project, titled "Action Likelihood to Evaluate Weakness, Abnormal Motor Synergies, and Spasticity in Stroke Survivors,"...
- The National Institute of Child Health and Human Development awarded the University of Maryland, Baltimore $433,595 on September 1, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to conduct a proof-of-concept study examining whether blood flow restriction combined with low-intensity resistance training enhances force generation and motor performance in stroke survivors with upper extremity paresis. The study will enroll thirty-two participants with...
- The National Institute of Mental Health awarded New York University $855,442 on September 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to characterize neural signatures of anxiety risk in infancy through longitudinal investigation of the mismatch negativity response as a potential biomarker. The project, titled "Characterizing Neural Signatures of Anxiety Risk in Infancy," recruits 250 mother-infant dyads at high risk for anxiety (with half of mothers carrying...
- The National Institute of Child Health and Human Development awarded The Spaulding Rehabilitation Hospital Corporation $170,640 on July 15, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to support a K23 career development award investigating childhood stroke predictors of motor recovery. The award funds a physician-scientist's career development and research program centered on neurorecovery mechanisms in pediatric acquired brain injury, with...
- The National Institute of Child Health and Human Development awarded Duke University $646,000 on June 16, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to conduct a dosing and deployment trial of EyeMove, a home-based optokinetic treatment for ipsilesional gaze deviation in stroke survivors with spatial neglect. The project tests the feasibility and acceptability of deploying EyeMove in community settings with 50 stroke survivors who have persistent...
- The National Institute of Child Health and Human Development awarded New York University $466,125 on September 1, 2026, under the Child Health and Human Development Extramural Research Program (CFDA 93.865) to validate scalable, gaze-based executive function assessment tasks for infants and toddlers ages 6 to 30 months. The research will develop and test two webcam-compatible, eye-tracking paradigms designed to measure inhibitory control, working memory, and cognitive flexibility in brief...
- The National Institute of Child Health and Human Development awarded Emory University $651,940 on September 1, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to investigate altered cortical control of heteronymous spinal reflex pathways as a mechanism of lower limb motor impairment after stroke. The research examines how damage to the motor cortex impairs modulatory control of heteronymous reflexes—spinal pathways that normally promote coordinated...
- The National Institute of Child Health and Human Development awarded Virginia Polytechnic Institute & State University $454,240 on August 15, 2026, under the Child Health and Human Development Extramural Research Projects program (CFDA 93.865) to conduct a longitudinal study measuring changes in peripheral nerve signaling following stroke. The research will examine whether brain lesions disrupt peripheral nerve function responsible for tactile perception, a gap in current understanding of...
- The National Institute of Child Health and Human Development awarded The Trustees of The University of Pennsylvania $444,470 on September 1, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.HDR) to develop a learning-from-demonstration framework enabling rehabilitation robots to automatically learn optimal assistance patterns from expert therapist demonstrations while adapting to individual patient capabilities in stroke neurorehabilitation. The research...
The National Institute of Child Health and Human Development awarded New York University $179,495 on September 1, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to investigate movement anxiety in stroke patients during inpatient rehabilitation. The research will prospectively track upper extremity movement anxiety in subacute stroke patients using the Tampa Scale of Kinesiophobia, clinical scales, electronic health record data, and wrist-worn accelerometers to measure 24-hour spontaneous upper extremity use. The study comprises three aims: identifying patient factors that predict higher movement anxiety (hypothesizing upper extremity pain as the primary contributor and pain catastrophizing as secondary); identifying patient and rehabilitation factors that influence changes in movement anxiety during the inpatient rehabilitation course; and determining the relationship between movement anxiety and upper extremity use. The research addresses a gap in understanding movement anxiety related to upper extremity use post-stroke, where 48–83 percent of stroke patients experience movement anxiety but current rehabilitation interventions do not target this issue. Place of performance is New York, New York. The award period runs from September 1, 2026, through August 31, 2031. New York University School of Medicine is the recipient and performing organization.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $179.5k | 8/31/26 |